2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Symptom Management: Pain, nausea, fatigue, and other common symptoms.
Managing symptoms like pain, nausea, and fatigue is a vital aspect of comprehensive cancer care, significantly impacting patients’ quality of life. Pain management often requires a multimodal approach, combining pharmacologic treatments, such as opioids and adjuvants, with non-pharmacologic strategies like physical therapy and mindfulness. For nausea, particularly chemotherapy-induced nausea and vomiting (CINV), antiemetics tailored to individual patient needs are essential. Fatigue, one of the most prevalent symptoms, benefits from interventions like structured exercise programs, adequate nutrition, and psychological support. Emerging therapies, including cannabis-based treatments, are also gaining attention for their efficacy in symptom relief. Addressing these symptoms proactively and holistically ensures that patients not only tolerate cancer treatments better but also maintain their overall well-being. Integrating symptom management into the care continuum underscores the importance of a patient-centered approach in oncology.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China